通过专为投资者打造的一站式数据看板，全面查看 Aytu Biopharma Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

19.89M

股息TTM

0.00

市盈率 TTM

-0.38

每股收益TTM

-4.61

营业收入

57.57M

净利润

-13.56M

净资产收益率

-97.42%

总资产收益率

-28.93%

Aytu Biopharma Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q4

FY2026Q3

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

财务指标

每股收益

99.96%0.00

-182.09%-0.53

-920.68%-1.05

-14.32%0.21

-255.48%-2.92

224.79%0.65

422.30%0.13

116.40%0.24

-35.86%-0.82

72.99%-0.52

98.15%-0.04

-432.02%-1.48

---0.60

---1.93

---2.15

---0.28

----

营业收入

6.42%16.11M

-32.74%12.41M

-6.51%15.16M

-16.21%13.89M

-15.80%15.13M

31.57%18.45M

-13.48%16.22M

-6.98%16.57M

-41.51%17.98M

-38.31%14.03M

-28.66%18.75M

-35.57%17.82M

11.96%30.73M

-6.06%22.73M

13.64%26.28M

26.30%27.66M

16.89%27.45M

79.49%24.20M

52.67%23.13M

61.96%21.90M

净利润

99.92%-15.00K

-240.66%-5.62M

-1443.15%-10.58M

33.31%1.97M

-329.24%-19.82M

238.34%3.99M

458.18%788.00K

118.15%1.47M

-87.91%-4.62M

59.90%-2.89M

96.71%-220.00K

-1058.35%-8.12M

84.73%-2.46M

86.49%-7.20M

42.04%-6.69M

97.48%-701.00K

15.31%-16.09M

-109.31%-53.29M

-21.24%-11.55M

-546.81%-27.85M

利润率

99.93%-0.09%

-311.99%-45.27%

-1802.41%-69.79%

114.55%14.15%

-411.41%-131.35%

230.89%21.35%

24.17%4.10%

115.72%6.59%

-221.26%-25.68%

48.49%-16.31%

112.96%3.30%

-1554.69%-41.94%

---7.99%

---31.67%

---25.47%

---2.53%

----

毛利率

-2.86%59.90%

-14.47%55.10%

-1.35%59.99%

-5.71%62.95%

4.54%61.67%

-4.31%64.42%

-16.68%60.82%

-1.82%66.76%

4.36%58.98%

32.55%67.32%

19.18%72.99%

11.69%67.99%

--56.52%

--50.79%

--61.25%

--60.88%

----

资产负债率

-7.67%16.22%

13.26%19.53%

25.79%17.16%

52.12%21.74%

37.13%17.57%

32.95%17.25%

11.58%13.64%

17.84%14.29%

6.85%12.81%

-23.90%12.97%

-21.60%12.22%

-19.39%12.13%

--11.99%

--17.05%

--15.59%

--15.05%

----

利润表

营业收入

6.42%16.11M

-32.74%12.41M

-6.51%15.16M

-16.21%13.89M

-15.80%15.13M

31.57%18.45M

-13.48%16.22M

-6.98%16.57M

-41.51%17.98M

-38.31%14.03M

-28.66%18.75M

-35.57%17.82M

11.96%30.73M

-6.06%22.73M

13.64%26.28M

26.30%27.66M

16.89%27.45M

79.49%24.20M

52.67%23.13M

61.96%21.90M

营业利润

-221.41%-777.00K

-267.86%-4.06M

-421.16%-1.97M

-930.14%-1.50M

141.86%640.00K

278.94%2.42M

-112.02%-378.00K

83.16%-146.00K

-154.43%-1.53M

85.44%-1.35M

175.03%3.15M

47.55%-867.00K

139.54%2.81M

1.77%-9.29M

62.87%-4.19M

79.95%-1.65M

36.38%-7.10M

51.02%-9.46M

-102.58%-11.29M

-131.84%-8.25M

净利润

99.92%-15.00K

-240.66%-5.62M

-1443.15%-10.58M

33.31%1.97M

-329.24%-19.82M

238.34%3.99M

458.18%788.00K

118.15%1.47M

-87.91%-4.62M

59.90%-2.89M

96.71%-220.00K

-1058.35%-8.12M

84.73%-2.46M

86.49%-7.20M

42.04%-6.69M

97.48%-701.00K

15.31%-16.09M

-109.31%-53.29M

-21.24%-11.55M

-546.81%-27.85M

资产负债表

流动资产

-22.00%61.76M

-7.15%67.33M

20.92%76.24M

33.54%81.11M

27.93%79.18M

1.94%72.51M

-11.65%63.05M

-13.97%60.74M

-15.02%61.89M

-9.35%71.13M

1.08%71.37M

-5.13%70.60M

21.53%72.83M

0.66%78.47M

-19.34%70.61M

-16.42%74.42M

-43.05%59.93M

-22.06%77.95M

-5.40%87.54M

36.03%89.04M

流动负债总额

-13.33%54.66M

-15.18%59.97M

2.37%65.56M

7.74%65.99M

1.34%63.06M

-15.51%70.71M

-0.22%64.05M

-6.43%61.25M

-9.83%62.23M

-2.02%83.69M

-4.41%64.19M

-10.57%65.46M

7.10%69.02M

6.29%85.42M

-33.23%67.15M

-25.30%73.20M

-41.12%64.44M

-3.97%80.36M

289.61%100.57M

355.67%98.00M

总资产

-15.44%105.01M

-10.07%111.69M

4.97%122.00M

7.91%124.99M

5.15%124.18M

-3.62%124.20M

-11.45%116.23M

-12.84%115.83M

-13.46%118.09M

-12.47%128.86M

-7.20%131.25M

-11.41%132.89M

-0.84%136.46M

-12.80%147.22M

-36.81%141.44M

-34.13%150.00M

-48.20%137.62M

-37.83%168.83M

34.23%223.82M

61.20%227.73M

总负债

-33.72%69.73M

-14.29%76.55M

26.14%107.80M

18.38%101.82M

16.41%105.21M

-8.95%89.30M

-13.14%85.46M

-14.61%86.00M

-6.93%90.38M

-7.73%98.09M

2.90%98.40M

4.82%100.72M

6.09%97.11M

-1.28%106.30M

-19.16%95.62M

-17.32%96.09M

-28.55%91.53M

-16.14%107.68M

118.85%118.29M

131.50%116.23M

总权益

85.99%35.27M

0.70%35.14M

-53.84%14.20M

-22.31%23.17M

-31.57%18.97M

13.39%34.90M

-6.36%30.77M

-7.28%29.83M

-29.58%27.72M

-24.77%30.78M

-28.30%32.85M

-40.33%32.17M

-14.61%39.36M

-33.09%40.91M

-56.59%45.82M

-51.65%53.91M

-66.50%46.09M

-57.29%61.14M

-6.35%105.54M

22.44%111.50M

现金流量表

经营净额

57.19%4.41M

35.21%-4.18M

26.51%3.67M

48.07%-618.00K

455.71%2.80M

-2441.34%-6.46M

2251.85%2.91M

-463.98%-1.19M

-108.41%-788.00K

91.26%-254.00K

94.47%-135.00K

97.69%-211.00K

231.99%9.37M

68.12%-2.91M

72.34%-2.44M

-141.31%-9.15M

-12.87%-7.09M

-3.84%-9.12M

-201.57%-8.82M

52.51%-3.79M

投资净额

99.60%-12.00K

100.00%0.00

-111.72%-17.00K

-100.00%0.00

-8773.53%-3.02M

-53.33%-69.00K

183.33%145.00K

601.32%381.00K

78.06%-34.00K

-4600.00%-45.00K

-3380.00%-174.00K

-280.95%-76.00K

-278.05%-155.00K

101.43%1.00K

99.84%-5.00K

148.84%42.00K

98.30%-41.00K

77.95%-70.00K

-10157.88%-3.05M

-855.56%-86.00K

融资净额

-136.95%-4.80M

-79.72%872.00K

-126.92%-6.26M

152.03%2.30M

1116.57%12.99M

711.13%4.30M

-2090.48%-2.76M

133.32%911.00K

119.76%1.07M

-79.48%530.00K

93.24%-126.00K

-120.17%-2.73M

-383.80%-5.40M

69.82%2.58M

-128.30%-1.86M

348.11%13.56M

-109.45%-1.12M

123.77%1.52M

-75.66%6.59M

-150.87%-5.46M

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

Aytu Biopharma Inc的总收入是多少？



根据Aytu Biopharma Inc的FY2026财报，总收入达到了57.57M（同比变化66.38M）。

Aytu Biopharma Inc的流动资产是多少？



根据Aytu Biopharma Inc的FY2026财报，流动资产为61.76M（同比变化-22.00）。

Aytu Biopharma Inc的总资产是多少？



根据Aytu Biopharma Inc的FY2026财报，Aytu Biopharma Inc的总资产为105.01M（同比变化-15.44）。

Aytu Biopharma Inc的总负债是多少？



根据Aytu Biopharma Inc的FY2026财报，Aytu Biopharma Inc的总负债为69.73M（同比变化-33.72）。

Aytu Biopharma Inc的总权益是多少？



根据Aytu Biopharma Inc的FY2026财报，Aytu Biopharma Inc的总权益为35.27M（同比变化85.99）。

Aytu Biopharma Inc的净营业收入是多少？



根据Aytu Biopharma Inc的FY2026财报，Aytu Biopharma Inc的净营业收入为-8.31M（同比变化-427.75）。

Aytu Biopharma Inc的净投资是多少？



根据Aytu Biopharma Inc的FY2026财报，Aytu Biopharma Inc的净投资为-29.00K（同比变化98.87）。

Aytu Biopharma Inc的净融资是多少？



根据Aytu Biopharma Inc的FY2026财报，Aytu Biopharma Inc的净融资为-7.90M（同比变化-151.13）。

Aytu Biopharma Inc的每股收益（EPS）是多少？



根据Aytu Biopharma Inc的FY2026财报，每股收益（EPS）为-1.16（同比变化46.43）。

Aytu Biopharma Inc的净利润是多少？



根据Aytu Biopharma Inc的FY2026财报，净利润为-14.25M（同比变化-5.09）。

Aytu Biopharma Inc的净利润率是多少？



根据Aytu Biopharma Inc的FY2026财报，净利润率为-24.76（同比变化-15.88）。

Aytu Biopharma Inc的毛利率是多少？



根据Aytu Biopharma Inc的FY2026财报，毛利率为59.62（同比变化-6.09）。

Aytu Biopharma Inc的债务与资产比率是多少？



根据Aytu Biopharma Inc的FY2026财报，债务与资产比率为16.22（同比变化-7.67）。

Aytu Biopharma Inc的股东权益回报率（ROE）是多少？



根据Aytu Biopharma Inc的FY2026财报，股东权益回报率（ROE）为-52.55（同比变化13.51）。

Aytu Biopharma Inc的资产回报率（ROA）是多少？



根据Aytu Biopharma Inc的FY2026财报，资产回报率（ROA）为-12.44（同比变化-6.23）。

Aytu Biopharma Inc的营业利润是多少？



根据Aytu Biopharma Inc的FY2026财报，营业利润为-8.31M（同比变化-427.75）。